Michael David Smith serves as Executive at KalVista Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Michael David Smith has executed 10 insider transactions totaling $459.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 13, 2024 involved transacting 32,422 shares valued at $0.
Michael David Smith currently holds 49,126 shares of KalVista Pharmaceuticals, Inc. (KALV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael David Smith has been a net seller of KALV stock. They have purchased $0 and sold $459.2K worth of shares.
Michael David Smith's most recent insider trade was on Mar 13, 2024, when they sold 32,422 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 8, 2022 | PTRA | $65.1K | Disposition | 8,812 | $7.39 | Discretionary |
| Feb 17, 2022 | PTRA | $0 | Award | 12,626 | $N/A | Discretionary |
| Nov 29, 2021 | PTRA | $0 | Award | 8,812 | $N/A | Discretionary |
| Jul 20, 2021 | PTRA | $27.6K | Award | 3,093 | $8.93 | Discretionary |
| Jun 1, 2021 | KALV | $62.9K | Option Exercise | 7,500 | $8.39 | Discretionary |
| Jun 1, 2021 | KALV | $201.2K | Sale | 7,500 | $26.83 | Discretionary |
| Apr 28, 2021 | KALV | $84.0K | Option Exercise | 10,014 | $8.39 | Discretionary |
| Apr 28, 2021 | KALV | $258.0K | Sale | 10,014 | $25.76 | Discretionary |